MedTrace Logo

Text Message (SMS) to Help Cancer Patients in Chemotherapy Treatment

NCT03087422 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2017-03-22

No results posted yet for this study

Summary

This study evaluates the text message (SMS) with orientation to help the management of chemotherapy treatment.

Conditions

Interventions

BEHAVIORAL

Text message intervention

The intervention consists in sending text messages with orientation that helps in homecare, specifically attempting to minimize chemotherapy side effects.

Sponsors & Collaborators

  • Samanta Winck Madruga

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-01
Primary Completion
2017-09-01
Completion
2017-12-15

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03087422 on ClinicalTrials.gov